Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Plasma donors can get a voucher for a flu shot and, yes, you can donate plasma after receiving the flu vaccine.
“People with rare diseases need more mental health support,” says researcher Kathleen Bogart.
Ahead of this year’s Congress of the European Society of Gene and Cell Therapies, we talked with Luigi Naldini, a pioneer in …
Niklas Elmehed has painted the distinctive portraits of Nobel Laureates since 2012. He recently captured the likeness of Emil…
Here are 5 things to know about this potential therapy.
Learn more about Emil von Behring, winner of the first Nobel Prize for Medicine in 1901.
With artificial intelligence, “we can get there faster, evaluate faster and relaunch faster when needed.”
A treatment made from donated plasma helps Rh-negative moms have healthy babies.
Thirty-seven students receive awards in the first year of a new program for employees and dependents.
Americas
Asia Pacific
Middle East
Europe